Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CNR2 Antikörper (AA 228-242)

CNR2 Reaktivität: Ratte WB, IHC Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN7043025
  • Target Alle CNR2 Antikörper anzeigen
    CNR2 (Cannabinoid Receptor 2 (CNR2))
    Bindungsspezifität
    • 15
    • 10
    • 9
    • 8
    • 5
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 228-242
    Reaktivität
    • 57
    • 20
    • 19
    • 2
    • 1
    • 1
    Ratte
    Wirt
    • 55
    • 1
    • 1
    Kaninchen
    Klonalität
    • 56
    • 1
    Polyklonal
    Konjugat
    • 26
    • 6
    • 5
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser CNR2 Antikörper ist unkonjugiert
    Applikation
    • 41
    • 26
    • 24
    • 18
    • 12
    • 12
    • 7
    • 6
    • 3
    • 3
    • 2
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC)
    Verwendungszweck
    A Rabbit Polyclonal Antibody to Cannabinoid Receptor 2
    Spezifität
    3rd intracellular loop
    Kreuzreaktivität
    Maus, Ratte
    Homologie
    Mouse - identical Human - 14 out of 15 amino acid residues identical
    Produktmerkmale
    Anti-Cannabinoid Receptor 2 Antibody (ABIN7043025, ABIN7044157 and ABIN7044158) is directed against an intracellular epitope of the rat CB2 receptor. Anti-Cannabinoid Receptor 2 Antibody (ABIN7043025, ABIN7044157 and ABIN7044158) can be used in western blot and immunohistochemistry applications, and recognizes CB2 in rat samples.
    Aufreinigung
    Affinity purified on immobilized antigen.
    Immunogen

    Immunogen: Synthetic peptide

    Immunogen Sequence: (C)DRQVPGIARMRLDVR, corresponding to amino acid residues 228-242 of rat CB2 receptor

    Isotyp
    IgG
    Top Product
    Discover our top product CNR2 Primärantikörper
  • Applikationshinweise

    Antigen preadsorption control: 1 μg peptide per 1 μg antibody

    Application Dilutions Immunohistochemistry paraffin embedded sections ihc: 1:100-1:400

    Application Dilutions Western blot wb: 1:200

    Kommentare

    Cited Application: IHC

    Negative Control: (ABIN7235032)

    Blocking Peptide: (ABIN7235032)

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Rekonstitution
    0.2 mL double distilled water (DDW).
    Konzentration
    1 mg/mL
    Buffer
    PBS pH 7.4
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung

    Storage before reconstitution: The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C.

    Storage after reconstitution: The reconstituted solution can be stored at 4°C for up to 1 week. For longer periods, small aliquots should be stored at -20°C. Avoid multiple freezing and thawing. Centrifuge all antibody preparations before use (10000 x g 5 min).

  • Target
    CNR2 (Cannabinoid Receptor 2 (CNR2))
    Andere Bezeichnung
    CNR2 (CNR2 Produkte)
    Hintergrund
    CB2, CNR2,Cannabinoids have been used as pain relievers in Eastern medicine for many years.1 To date, two specific cannabinoid receptors have been identified: cannabinoid receptor 1 (CB1) and cannabinoid receptor 2 (CB2).2 The cannabinoid receptors can be distinguished by their amino acid sequence, signaling mechanisms and tissue distribution.2 Both receptors belong to the G-protein coupled receptor superfamily and are coupled to Gi/0 G protein.2,3The CB2 receptor is highly expressed in cells of the immune system such as macrophages, lymphocytes natural killer cells and mast cells but has also been shown to be expressed, by both, in situ-hybridization and in immunohistochemistry, in spleen, thymus, and pancreas.1,2,4 CB2 expression in the brain is still much less characterized than that of CB1. Recently, it was demonstrated that CB2 is expressed in the brain and might have a role in controlling fundamental processes such as proliferation and survival of neural cells.5,6Overexpression of CB2 was reported in several cancers such as prostate, glioma and acute myeloid leukemias.6 In human astrocytoma a direct relationship between CB2 expression and tumor malignancy was demonstrated. Activation of CB2 in vivo by its agonist JWH-133, completely blocked cell growth. In C6 glioma, it was shown that activation of the CB2 by JWH-133 resulted in the internalization of only the CB2 and not CB1 leading to apoptosis of the cells. This may well be a new approach for the treatment of glioma.7

    Alternative names: Cannabinoid Receptor 2, CB2, CNR2
    Gen-ID
    57302
    NCBI Accession
    NM_001841
    UniProt
    Q9QZN9
Sie sind hier:
Chat with us!